Media center

See Moderna’s Ad from the 2022 US Open

Moderna Celebrates Lunar New Year

The People Behind the Science: Meet Amy!

Why I Work at Moderna 2021

Celebrating Clinical Trial Day: Thank You Participants

Celebrating Clinical Trials Day: Thank You Investigators

Celebrating Clinical Trials Day

How Lipid Nanoparticles (LNPs) Dutifully Deliver mRNA

Stronger Together: A Community Effort to Support People with Rare Metabolic Disorders

CMV voices: Farah's Story

CMV voices: Cara's Story

CMV voices: Acantha's Story

Voice of the CMV Patient

Moderna and the Propionic Acidemia Foundation

mRNA-3704 and Methylmalonic Acidemia

Why I Work At Moderna

Moderna’s Clinical Development Manufacturing Facility

How Moderna Makes and Delivers Personalized Cancer Vaccines

New Manufacturing Site in Norwood, MA

Pursuing KRAS: Amplifying Checkpoint Inhibitors with mRNA Cancer Vaccines

The Potential of Moderna's mRNA Platform for Developing a Vaccine to Fight CMV

Delivering on the promise of mRNA therapies for rare diseases

Advancing mRNA-based personalized cancer vaccines – Tal Zaks, MD, PhD, Moderna CMO

Moderna Early Development Engine - October 2017

Moderna Mission - October 2017

Moderna Research Engine, Oct 2017

Moderna’s Digitization Building Blocks

Advantages of mRNA Vaccines